These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 35372493)

  • 1. Survival After Lobectomy vs. Sublobar Resection for Stage IA Large-Cell Neuroendocrine Carcinoma of the Lung: A Population-Based Study.
    Yu X; Zhang M; Wang F; Guo X; Ma K; Wang L; Zhao H; Xiao H; Huang C; Du L; Jia R; Yang Y; Zhang L; Yu Z
    Front Surg; 2022; 9():856048. PubMed ID: 35372493
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sublobar resection is associated with decreased survival for patients with early stage large-cell neuroendocrine carcinoma of the lung.
    Lutfi W; Schuchert MJ; Dhupar R; Sarkaria I; Christie NA; Yang CJ; Deng JZ; Luketich JD; Okusanya OT
    Interact Cardiovasc Thorac Surg; 2019 Oct; 29(4):517-524. PubMed ID: 31177277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extent of lymphadenectomy is associated with oncological efficacy of sublobar resection for lung cancer ≤2 cm.
    Stiles BM; Mao J; Harrison S; Lee B; Port JL; Sedrakyan A; Altorki NK
    J Thorac Cardiovasc Surg; 2019 Jun; 157(6):2454-2465.e1. PubMed ID: 30954298
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcomes for Surgery in Stage IA Large Cell Lung Neuroendocrine Compared With Other Types of Non-Small Cell Lung Cancer: A Propensity Score Matching Study Based on the Surveillance, Epidemiology, and End Results (SEER) Database.
    Zou L; Guo T; Ye L; Zhou Y; Chu L; Chu X; Ni J; Zhu Z; Yang X
    Front Oncol; 2020; 10():572462. PubMed ID: 33324549
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sublobar resection versus lobectomy for patients with stage T1-2N0M0 pulmonary typical carcinoid tumours: a population-based propensity score matching analysis.
    Yang H; Mei T
    Interact Cardiovasc Thorac Surg; 2022 Aug; 35(3):. PubMed ID: 35512177
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term survival analysis of sublobar resection versus lobectomy for older patients with early-stage pulmonary carcinoid tumour: a database-based propensity score-matched study.
    Yang H; Xiao X; Mei T; Zhou P
    Aging Clin Exp Res; 2022 Aug; 34(8):1925-1934. PubMed ID: 35347580
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sublobar resection versus lobectomy in patients aged ≤35 years with stage IA non-small cell lung cancer: a SEER database analysis.
    Gu C; Wang R; Pan X; Huang Q; Zhang Y; Yang J; Shi J
    J Cancer Res Clin Oncol; 2017 Nov; 143(11):2375-2382. PubMed ID: 28819775
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Segmental resection is associated with decreased survival in patients with stage IA non-small cell lung cancer with a tumor size of 21-30 mm.
    Yu X; Zhang R; Zhang M; Lin Y; Zhang X; Wen Y; Yang L; Huang Z; Wang G; Zhao D; Gonzalez M; Baste JM; Petersen RH; Ng CSH; Brunelli A; Zheng L; Zhang L;
    Transl Lung Cancer Res; 2021 Feb; 10(2):900-913. PubMed ID: 33718031
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selection of the surgical approach for patients with cStage IA lung squamous cell carcinoma: A population-based propensity score matching analysis.
    Shao S; Song G; Wang Y; Yi T; Li S; Chen F; Li Y; Liu X; Han B; Liu Y
    Front Oncol; 2022; 12():946800. PubMed ID: 36081555
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcomes of sublobar resection vs lobectomy for invasive clinical stage T1N0 non-small-cell lung cancer: A propensity-match analysis.
    Wald O; Sadeh BM; Bdolah-Abram T; Erez E; Shapira OM; Izhar U
    Cancer Rep (Hoboken); 2021 Jun; 4(3):e1339. PubMed ID: 33570255
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sublobar resection is equivalent to lobectomy for clinical stage 1A lung cancer in solid nodules.
    Altorki NK; Yip R; Hanaoka T; Bauer T; Aye R; Kohman L; Sheppard B; Thurer R; Andaz S; Smith M; Mayfield W; Grannis F; Korst R; Pass H; Straznicka M; Flores R; Henschke CI;
    J Thorac Cardiovasc Surg; 2014 Feb; 147(2):754-62; Discussion 762-4. PubMed ID: 24280722
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of prognostic impact of lymphovascular invasion in stage IA non-small cell lung cancer after lobectomy versus sublobar resection: A propensity score-matched analysis.
    Yun JK; Lee GD; Choi S; Kim HR; Kim YH; Kim DK; Park SI
    Lung Cancer; 2020 Aug; 146():105-111. PubMed ID: 32526600
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sublobar resection for node-negative lung cancer 2-5 cm in size.
    Stiles BM; Mao J; Harrison S; Lee B; Port JL; Altorki NK; Sedrakyan A
    Eur J Cardiothorac Surg; 2019 Nov; 56(5):858-866. PubMed ID: 31168591
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimal Surgery Type and Adjuvant Therapy for T1N0M0 Lung Large Cell Neuroendocrine Carcinoma.
    Peng K; Cao H; You Y; He W; Jiang C; Wang L; Jin Y; Xia L
    Front Oncol; 2021; 11():591823. PubMed ID: 33868992
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of Lobectomy and Sublobar Resection for Stage IA Elderly NSCLC Patients (≥70 Years): A Population-Based Propensity Score Matching's Study.
    Zhang B; Liu R; Ren D; Li X; Wang Y; Huo H; Zhu S; Chen J; Song Z; Xu S
    Front Oncol; 2021; 11():610638. PubMed ID: 34026604
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the outcomes of sublobar resection and stereotactic body radiotherapy for stage T1-2N0M0 non-small cell lung cancer with tumor size ≤ 5 cm: a propensity score matching analysis.
    Dong B; Zhu X; Jin J; Chen Y; Ying H; Chen Y; Lu F; Shen W; Wang J; Chen M
    J Thorac Dis; 2020 Oct; 12(10):5934-5954. PubMed ID: 33209426
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic Analysis of Limited Resection Versus Lobectomy in Stage IA Small Cell Lung Cancer Patients Based on the Surveillance, Epidemiology, and End Results Registry Database.
    Gu C; Huang Z; Dai C; Wang Y; Ren Y; She Y; Su H; Chen C
    Front Genet; 2018; 9():568. PubMed ID: 30524472
    [No Abstract]   [Full Text] [Related]  

  • 18. Lobectomy versus sub-lobar resection in patients with stage IA right middle lobe non-small cell lung cancer: a propensity score matched analysis.
    Lin G; Liu H; Li J
    J Thorac Dis; 2019 Jun; 11(6):2523-2534. PubMed ID: 31372289
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A propensity-matched analysis of stereotactic body radiotherapy and sublobar resection for stage I non-small cell lung cancer in patients at high risk for lobectomy: the results in a Chinese population.
    Yuan XS; Chen WC; Lin QR; Liu YJ; Zhu YY; Sun XJ; Wu QY; Liu JS; Xu YP
    J Thorac Dis; 2021 Mar; 13(3):1822-1832. PubMed ID: 33841971
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-Term Results for Clinical Stage IA Lung Cancer: Comparing Lobectomy and Sublobar Resection.
    Subramanian M; McMurry T; Meyers BF; Puri V; Kozower BD
    Ann Thorac Surg; 2018 Aug; 106(2):375-381. PubMed ID: 29580779
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.